Skip to content

A prospective, multicentre, one-arm, non-interventional real-world study evaluating traditional Chinese medicine for the prevention and treatment of pulmonary nodules based on sputum toxicity theory

A prospective, multicentre, one-arm, non-interventional real-world study evaluating traditional Chinese medicine for the prevention and treatment of pulmonary nodules based on sputum toxicity theory

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074851
Enrollment
Unknown
Registered
2023-08-17
Start date
2023-08-09
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary nodules

Interventions

Case series:NA

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-80, gender unlimited; 2. Pulmonary nodules (diameter = 3cm) found by chest CT (plain scan, enhanced scan, PET-CT) meet the diagnostic criteria for single or multiple pulmonary nodules; 3. The subjects had no dysfunction of vital organs, normal blood routine, liver, kidney and heart function; 4. The patient signed the informed consent, voluntarily accepted the follow-up, and the compliance was good.

Exclusion criteria

Exclusion criteria: 1. Patients in the acute stage of lung disease assessed by a specialist; 2. Unable to provide complete baseline data; 3. Unable to cooperate with follow-up or serious mental illness.

Design outcomes

Primary

MeasureTime frame
Distribution law of TCM syndrome type;Prevention and treatment of pulmonary nodules by different treatment methods;

Secondary

MeasureTime frame
Study on the correlation between TCM syndrome type of pulmonary nodules and probability of malignant transformation;Lung nodule characteristics and AI intelligent image analysis results;Peripheral blood CAC test results;Disease progression time;

Countries

China

Contacts

Public ContactLin Lizhu

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

13501505588@139.com+86 135 0150 5588

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026